LaunchTrends®

Insights on Uptake of New products and the Impact of New Products on Market Dynamics

LaunchTrends are syndicated report series that track the trial, adoption and usage of new products. These report series provide information on how new products fit into the treatment algorithm, impact current therapies, and change market dynamics. They provide information on awareness, familiarity, and perceived clinical advantages and disadvantages of new products. And, they capture the promotional messages and activities of key market players.

Scope:

• Detailed analysis of product awareness, perceptions, satisfaction, trial, use, obstacles to use, reasons for use, dosing strategies, displacement of competitors, promotional efforts, and benchmarking against other newly approved agents
• U.S. coverage (based on FDA approval)
• Fielded at one, three and six months post commercial availability of newly FDA-approved agents
• Quantitative survey of 75+ unique practicing physicians per wave and qualitative interviews with a subset of 30 physicians per wave

Sample Questions LaunchTrends Series Can Help Answer:

• What percent of physicians have used the newly approved product and to what extent have they used the product?
• What percent of patients are likely candidates for the newly approved product?
• What products are being displaced by the newly approved product?
• What are the perceived advantages and disadvantages of the newly approved product?
• What are the key obstacles and drivers for use?
• In what patient types are physicians using the newly approved product?
• What information is needed to increase comfort with prescribing the newly approved product?
• What are the promotional messages being employed by company representatives? How effective are these messages?
• What products "own" the various attributes that are important when choosing an agent to treat the disease? What products are least associated with these attributes?